- Home
- Publications
- Publication Search
- Publication Details
Title
PCSK9: A novel inflammation modulator in atherosclerosis?
Authors
Keywords
-
Journal
JOURNAL OF CELLULAR PHYSIOLOGY
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2018-09-24
DOI
10.1002/jcp.27254
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- PCSK9 plays a novel immunological role in oxidized LDL-induced dendritic cell maturation and activation of T cells from human blood and atherosclerotic plaque
- (2018) A. Liu et al. JOURNAL OF INTERNAL MEDICINE
- PCSK9 induces a pro-inflammatory response in macrophages
- (2018) Chiara Ricci et al. Scientific Reports
- PCSK9 monoclonal antibodies reverse the pro-inflammatory profile of monocytes in familial hypercholesterolaemia
- (2017) Sophie J. Bernelot Moens et al. EUROPEAN HEART JOURNAL
- The AT04A vaccine against proprotein convertase subtilisin/kexin type 9 reduces total cholesterol, vascular inflammation, and atherosclerosis in APOE*3Leiden.CETP mice
- (2017) Christine Landlinger et al. EUROPEAN HEART JOURNAL
- PCSK9 in chronic kidney disease
- (2017) P. Pavlakou et al. INTERNATIONAL UROLOGY AND NEPHROLOGY
- PCSK9 and Atherosclerosis - Lipids and Beyond
- (2017) Michael D. Shapiro et al. Journal of Atherosclerosis and Thrombosis
- PCSK9 at the crossroad of cholesterol metabolism and immune function during infections
- (2017) Francesco Paciullo et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Investigation of highly expressed PCSK9 in atherosclerotic plaques and ox-LDL-induced endothelial cell apoptosis
- (2017) Jiao Li et al. Molecular Medicine Reports
- Atherosclerosis: PCSK9 inhibition reduces cardiovascular events in high-risk patients
- (2017) Karina Huynh Nature Reviews Cardiology
- Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease
- (2017) Marc S. Sabatine et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cardiovascular Efficacy and Safety of Bococizumab in High-Risk Patients
- (2017) Paul M Ridker et al. NEW ENGLAND JOURNAL OF MEDICINE
- Linking resistin, inflammation, and cardiometabolic diseases
- (2017) Hyeong Kyu Park et al. KOREAN JOURNAL OF INTERNAL MEDICINE
- Cross-Talk Between PCSK9 and Damaged mtDNA in Vascular Smooth Muscle Cells: Role in Apoptosis
- (2016) Zufeng Ding et al. ANTIOXIDANTS & REDOX SIGNALING
- Inflammation in atherosclerosis
- (2016) Soraya Taleb Archives of Cardiovascular Diseases
- PCSK9 and atherosclerosis: Beyond LDL-cholesterol lowering
- (2016) Bertrand Cariou et al. ATHEROSCLEROSIS
- PCSK9 in relation to coronary plaque inflammation: Results of the ATHEROREMO-IVUS study
- (2016) Jin M. Cheng et al. ATHEROSCLEROSIS
- Human PCSK9 promotes hepatic lipogenesis and atherosclerosis development via apoE- and LDLR-mediated mechanisms
- (2016) Hagai Tavori et al. CARDIOVASCULAR RESEARCH
- Biology of proprotein convertase subtilisin kexin 9: beyond low-density lipoprotein cholesterol lowering
- (2016) Giuseppe Danilo Norata et al. CARDIOVASCULAR RESEARCH
- LOX-1-Mediated Effects on Vascular Cells in Atherosclerosis
- (2016) Dimitry A. Chistiakov et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Circulating Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Predicts Future Risk of Cardiovascular Events Independently of Established Risk FactorsCLINICAL PERSPECTIVE
- (2016) Karin Leander et al. CIRCULATION
- The role of mitochondrial DNA damage in the development of atherosclerosis
- (2016) Emma P.K. Yu et al. FREE RADICAL BIOLOGY AND MEDICINE
- Association between plasma PCSK9 levels and 10-year progression of carotid atherosclerosis beyond LDL-C: A cohort study
- (2016) Wuxiang Xie et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- A review of PCSK9 inhibition and its effects beyond LDL receptors
- (2016) Dave L. Dixon et al. Journal of Clinical Lipidology
- Increased Plasma PCSK9 Levels Are Associated with Reduced Endotoxin Clearance and the Development of Acute Organ Failures during Sepsis
- (2016) John H. Boyd et al. Journal of Innate Immunity
- Both STAT3 activation and cholesterol efflux contribute to the anti-inflammatory effect of apoA-I/ABCA1 interaction in macrophages
- (2016) Chongren Tang et al. JOURNAL OF LIPID RESEARCH
- LRP1 modulates the microglial immune response via regulation of JNK and NF-κB signaling pathways
- (2016) Longyu Yang et al. Journal of Neuroinflammation
- Targeting PCSK9 as a promising new mechanism for lowering low-density lipoprotein cholesterol
- (2016) Laura A. Della Badia et al. PHARMACOLOGY & THERAPEUTICS
- LDL receptor-related protein-1 regulates NFκB and microRNA-155 in macrophages to control the inflammatory response
- (2016) Elisabetta Mantuano et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Differential Expression of PCSK9 Modulates Infection, Inflammation, and Coagulation in a Murine Model of Sepsis
- (2016) Dhruva J. Dwivedi et al. SHOCK
- Vascular smooth muscle cell in atherosclerosis
- (2015) D. A. Chistiakov et al. Acta Physiologica
- The Central Role of Proprotein Convertase Subtilisin/Kexin Type 9 in Septic Pathogen Lipid Transport and Clearance
- (2015) Keith R. Walley et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Hemodynamic Shear Stress via ROS Modulates PCSK9 Expression in Human Vascular Endothelial and Smooth Muscle Cells and Along the Mouse Aorta
- (2015) Zufeng Ding et al. ANTIOXIDANTS & REDOX SIGNALING
- The association of resistin with cardiovascular disease in the Multi-Ethnic Study of Atherosclerosis
- (2015) Evan D. Muse et al. ATHEROSCLEROSIS
- Cross-talk between LOX-1 and PCSK9 in vascular tissues
- (2015) Zufeng Ding et al. CARDIOVASCULAR RESEARCH
- Role of PCSK9 beyond liver involvement
- (2015) Bertrand Cariou et al. CURRENT OPINION IN LIPIDOLOGY
- Prognostic value of PCSK9 levels in patients with acute coronary syndromes
- (2015) Baris Gencer et al. EUROPEAN HEART JOURNAL
- Efficacy and safety of alirocumab in high cardiovascular risk patients with inadequately controlled hypercholesterolaemia on maximally tolerated doses of statins: the ODYSSEY COMBO II randomized controlled trial
- (2015) Christopher P. Cannon et al. EUROPEAN HEART JOURNAL
- PCSK9: A key factor modulating atherosclerosis
- (2015) Sha Li et al. Journal of Atherosclerosis and Thrombosis
- Suppressor of Cytokine Signaling-3 (SOCS-3) Induces Proprotein Convertase Subtilisin Kexin Type 9 (PCSK9) Expression in Hepatic HepG2 Cell Line
- (2015) Massimiliano Ruscica et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Local effects of human PCSK9 on the atherosclerotic lesion
- (2015) Ilaria Giunzioni et al. JOURNAL OF PATHOLOGY
- National prevalence of coronary heart disease and its relationship with human development index: A systematic review
- (2015) Ke-Fu Zhu et al. European Journal of Preventive Cardiology
- Relation of resistin to proprotein convertase subtilisin–kexin type 9 levels in coronary artery disease patients with different nutritional status
- (2015) S. Li et al. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
- Association of plasma PCSK9 levels with white blood cell count and its subsets in patients with stable coronary artery disease
- (2014) Sha Li et al. ATHEROSCLEROSIS
- Role of vascular smooth muscle cell in the inflammation of atherosclerosis
- (2014) Soyeon Lim et al. BMB Reports
- LOX-1, oxidant stress, mtDNA damage, autophagy, and immune response in atherosclerosis
- (2014) Zufeng Ding et al. CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY
- PCSK9
- (2014) Nabil G. Seidah et al. CIRCULATION RESEARCH
- Resistin: An Inflammatory Cytokine. Role in Cardiovascular Diseases, Diabetes and the Metabolic Syndrome
- (2014) Nicola Abate et al. CURRENT PHARMACEUTICAL DESIGN
- LOX-1 and ROS, inseparable factors in the process of endothelial damage
- (2014) V. Lubrano et al. FREE RADICAL RESEARCH
- Shear-sensitive microRNA-34a modulates flow-dependent regulation of endothelial inflammation
- (2014) W. Fan et al. JOURNAL OF CELL SCIENCE
- Relation of circulating PCSK9 concentration to fibrinogen in patients with stable coronary artery disease
- (2014) Yan Zhang et al. Journal of Clinical Lipidology
- Alirocumab inhibits atherosclerosis, improves the plaque morphology, and enhances the effects of a statin
- (2014) Susan Kühnast et al. JOURNAL OF LIPID RESEARCH
- Shear Stress and Atherosclerosis
- (2014) Kyung-Sun Heo et al. MOLECULES AND CELLS
- PCSK9 is a critical regulator of the innate immune response and septic shock outcome
- (2014) K. R. Walley et al. Science Translational Medicine
- Mitochondrial DNA damage and atherosclerosis
- (2014) Emma P.K. Yu et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- PCSK9 plays a significant role in cholesterol homeostasis and lipid transport in intestinal epithelial cells
- (2013) Emile Levy et al. ATHEROSCLEROSIS
- Low density receptor-related protein 1 (LRP1) promotes anti-inflammatory phenotype in murine macrophages
- (2013) Petra May et al. CELL AND TISSUE RESEARCH
- Inflammation and Atherosclerosis—Revisited
- (2013) Sadip Pant et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS
- The influence of factors on dewaterability of one-stage autothermal thermophilic aerobically digested sludges
- (2013) Jiehong Cheng et al. WORLD JOURNAL OF MICROBIOLOGY & BIOTECHNOLOGY
- Fibrinogen facilitates atherosclerotic formation in Sprague-Dawley rats: A rodent model of atherosclerosis
- (2013) BIRONG ZHOU et al. Experimental and Therapeutic Medicine
- Inflammation in Atherosclerosis
- (2012) Peter Libby ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- White blood cell count is associated with carotid and femoral atherosclerosis
- (2012) Emilio Ortega et al. ATHEROSCLEROSIS
- The Biological Role of Inflammation in Atherosclerosis
- (2012) Brian W. Wong et al. CANADIAN JOURNAL OF CARDIOLOGY
- Smooth muscle cell phenotypic switching in atherosclerosis
- (2012) D. Gomez et al. CARDIOVASCULAR RESEARCH
- LOX-1 in atherosclerosis: biological functions and pharmacological modifiers
- (2012) Suowen Xu et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Gene Inactivation of Proprotein Convertase Subtilisin/Kexin Type 9 Reduces Atherosclerosis in Mice
- (2012) Maxime Denis et al. CIRCULATION
- PCSK9 siRNA suppresses the inflammatory response induced by oxLDL through inhibition of NF-κB activation in THP-1-derived macrophages
- (2012) ZHIHAN TANG et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- Celastrol attenuates adipokine resistin-associated matrix interaction and migration of vascular smooth muscle cells
- (2012) Sang-Wook Kang et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Discovery of a New Role of Human Resistin in Hepatocyte Low-Density Lipoprotein Receptor Suppression Mediated in Part by Proprotein Convertase Subtilisin/Kexin Type 9
- (2012) Michelle Melone et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Effect of Porphyromonas gingivalis infection on post-transcriptional regulation of the low-density lipoprotein receptor in mice
- (2012) Haruna Miyazawa et al. Lipids in Health and Disease
- White Blood Cell Count and the Risk for Coronary Artery Disease in Young Adults
- (2012) Gilad Twig et al. PLoS One
- Apolipoprotein E Induces Antiinflammatory Phenotype in Macrophages
- (2011) Daniel Baitsch et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Monocyte and Macrophage Dynamics During Atherogenesis
- (2011) Klaus Ley et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Proprotein convertase subtilisin kexin type 9 (PCSK9) secreted by cultured smooth muscle cells reduces macrophages LDLR levels
- (2011) Nicola Ferri et al. ATHEROSCLEROSIS
- Resistin: functional roles and therapeutic considerations for cardiovascular disease
- (2011) Md S Jamaluddin et al. BRITISH JOURNAL OF PHARMACOLOGY
- Human Vascular Endothelial Cells: A Model System for Studying Vascular Inflammation in Diabetes and Atherosclerosis
- (2011) Duygu Onat et al. Current Diabetes Reports
- Unexpected roles for PCSK9 in lipid metabolism
- (2011) Anne K Soutar CURRENT OPINION IN LIPIDOLOGY
- PCSK9 siRNA inhibits HUVEC apoptosis induced by ox-LDL via Bcl/Bax–caspase9–caspase3 pathway
- (2011) Chun-Yan Wu et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- A Prospective Natural-History Study of Coronary Atherosclerosis
- (2011) Gregg W. Stone et al. NEW ENGLAND JOURNAL OF MEDICINE
- Fibrinogen as a key regulator of inflammation in disease
- (2011) Dimitrios Davalos et al. Seminars in Immunopathology
- Flow Shear Stress and Atherosclerosis: A Matter of Site Specificity
- (2010) Patrizia Nigro et al. ANTIOXIDANTS & REDOX SIGNALING
- Role of hemodynamic shear stress in cardiovascular disease
- (2010) Emanuele Cecchi et al. ATHEROSCLEROSIS
- Immune and Inflammatory Mechanisms of Atherosclerosis
- (2009) Elena Galkina et al. Annual Review of Immunology
- PCSK9 is expressed in pancreatic δ-cells and does not alter insulin secretion
- (2009) Cédric Langhi et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- The role of resistin as a regulator of inflammation: Implications for various human pathologies
- (2009) Mária Filková et al. CLINICAL IMMUNOLOGY
- Growing Epidemic of Coronary Heart Disease in Low- and Middle-Income Countries
- (2009) Thomas A. Gaziano et al. CURRENT PROBLEMS IN CARDIOLOGY
- The Macrophage Cholesterol Exporter ABCA1 Functions as an Anti-inflammatory Receptor
- (2009) Chongren Tang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Resistin competes with lipopolysaccharide for binding to toll-like receptor 4
- (2009) Andrej Tarkowski et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- The connection between C‐reactive protein and atherosclerosis
- (2008) Sanjay K. Singh et al. ANNALS OF MEDICINE
- Inflammation stimulates the expression of PCSK9
- (2008) Kenneth R. Feingold et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Increased Cellular Free Cholesterol in Macrophage-specificAbca1Knock-out Mice Enhances Pro-inflammatory Response of Macrophages
- (2008) Xuewei Zhu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started